Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis

BACKGROUND: In advanced prostate cancer, osteoclast inhibitors prevent and palliate skeletal related events associated with bone metastases. However, it is uncertain whether they play a disease-modifying role earlier in the course of the disease. METHODS: Medline, EMBASE, Cochrane Central Register o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Aimee R., Brungs, Daniel, Pavlakis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784941/
https://www.ncbi.nlm.nih.gov/pubmed/29370211
http://dx.doi.org/10.1371/journal.pone.0191455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784941/
https://www.ncbi.nlm.nih.gov/pubmed/29370211
http://dx.doi.org/10.1371/journal.pone.0191455

Ejemplares similares